RESUMO
An increasing number of patients older than 65 years are referred for and have access to organ transplantation, and an increasing number of older adults are donating organs. Although short-term outcomes are similar in older versus younger transplant recipients, older donor or recipient age is associated with inferior long-term outcomes. However, age is often a proxy for other factors that might predict poor outcomes more strongly and better identify patients at risk for adverse events. Approaches to transplantation in older adults vary across programs, but despite recent gains in access and the increased use of marginal organs, older patients remain less likely than other groups to receive a transplant, and those who do are highly selected. Moreover, few studies have addressed geriatric issues in transplant patient selection or management, or the implications on health span and disability when patients age to late life with a transplanted organ. This paper summarizes a recent trans-disciplinary workshop held by ASP, in collaboration with NHLBI, NIA, NIAID, NIDDK and AGS, to address issues related to kidney, liver, lung, or heart transplantation in older adults and to propose a research agenda in these areas.
Assuntos
Transplante de Órgãos , Idoso , Alocação de Recursos para a Atenção à Saúde , Humanos , Imunossupressores/uso terapêutico , Seleção de Pacientes , Justiça Social , Doadores de Tecidos , Resultado do TratamentoRESUMO
Efforts to prevent relapsed cytomegalovirus (CMV) disease among solid organ transplant (SOT) recipients present clinical challenges. Historically, SOT recipients treated with short courses of ganciclovir, without documented clearance of viremia, had relapse rates of 23-33%. Current treatment often includes much longer courses of valganciclovir, and persistence of viremia at the end of treatment is rare. We sought to determine the rate and risk factors for relapse under those treatment conditions. Records of 1760 SOT recipients from January 2003 to June 2007 were reviewed; 105 cases of CMV viremia were identified. Relapse occurred in 20/105 (19%); 50% had end-organ disease at the time of relapse. Most patients received approximately 3 months of valganciclovir. Clearance of viremia was documented in 19/20 patients with relapse. Multivariable analysis identified receipt of a thoracic organ and diabetes mellitus as risk factors for relapse. Despite long treatment courses with valganciclovir and documented clearance of viremia, CMV relapse remains common among SOT recipients. Better understanding of the epidemiology of CMV among SOT recipients and validation of risk factors for disease relapse should be the focus of future prospective trials. Such trials should include different treatment durations and extended monitoring for relapse.
Assuntos
Infecções por Citomegalovirus/prevenção & controle , Citomegalovirus , Transplante de Órgãos/efeitos adversos , Viremia/prevenção & controle , Adulto , Idoso , Antivirais/uso terapêutico , Quimioprevenção , Citomegalovirus/genética , Citomegalovirus/isolamento & purificação , Infecções por Citomegalovirus/diagnóstico , Infecções por Citomegalovirus/tratamento farmacológico , Infecções por Citomegalovirus/virologia , Feminino , Ganciclovir/análogos & derivados , Ganciclovir/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva , Fatores de Risco , Valganciclovir , Viremia/diagnóstico , Viremia/tratamento farmacológico , Viremia/virologia , Adulto JovemRESUMO
The radiologist plays a crucial role in identifying and narrowing the differential diagnosis of intracranial infections. A thorough understanding of the intracranial compartment anatomy and characteristic imaging findings of specific pathogens, as well incorporation of the clinical information, is essential to establish correct diagnosis. Specific types of infections have certain propensities for different anatomical regions within the brain. In addition, the imaging findings must be placed in the context of the clinical setting, particularly in immunocompromised and human immunodeficiency virus (HIV)-positive patients. This paper describes and depicts infections within the different compartments of the brain. Pathology-proven infectious cases are presented in both immunocompetent and immunocompromised patients, with a discussion of the characteristic findings of each pathogen. Magnetic resonance spectroscopy (MRS) characteristics for several infections are also discussed.
Assuntos
Encefalopatias/diagnóstico , Diagnóstico por Imagem/métodos , Infecções/diagnóstico , Adulto , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/microbiologia , Abscesso Encefálico/diagnóstico , Encefalopatias/microbiologia , Encefalopatias/parasitologia , Encefalopatias/virologia , Criança , Diagnóstico Diferencial , Empiema Subdural/diagnóstico , Encefalite/diagnóstico , Encefalite/microbiologia , Encefalite/virologia , Abscesso Epidural/diagnóstico , Infecções por HIV/diagnóstico , Humanos , Infecções/microbiologia , Infecções/parasitologia , Infecções/virologia , Doença de Lyme/diagnóstico , Meningite/diagnóstico , Micoses/diagnóstico , Doenças Parasitárias/diagnóstico , Doenças Parasitárias/parasitologia , Tuberculose do Sistema Nervoso Central/diagnóstico , Viroses/diagnósticoRESUMO
After noting a rise in vancomycin-resistant enterococci (VRE) infections, we initiated a program to decrease inappropriate vancomycin use that focused on improvement of house staff prescribing practices. The initial intervention in June, 1995, encouraging house staff to follow hospital guidelines for vancomycin use and eliciting support from service chiefs in this effort, had little impact. A more intensive educational intervention, beginning in January, 1996, involved concurrent review of all vancomycin orders and one-on-one discussion with the house staff regarding the rationale for the order by an infectious diseases clinical pharmacist. When usage was deemed inappropriate, the pharmacist asked that vancomycin be discontinued, but no automatic stop orders were issued. During the next two and one-half years, this second intervention proved effective at decreasing inappropriate use from 39% to 16.8% +/- 2.4% (p = 0.005). This change was primarily due to a decrease in appropriate vancomycin prophylaxis by cardiothoracic surgery. VRE infections decreased from 0.29/100 patients discharged prior to initiating the program to 0.13/100 patients discharged after the second intervention (p = 0.01). This educational program, although labor-intensive, preserved house staff decision-making skills related to antibiotic prescribing at the same time that it decreased inappropriate vancomycin use.
Assuntos
Prescrições de Medicamentos , Enterococcus/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/microbiologia , Resistência a Vancomicina , Vancomicina/administração & dosagem , Antibioticoprofilaxia , Uso de Medicamentos , Enterococcus/fisiologia , Infecções por Bactérias Gram-Positivas/prevenção & controle , Humanos , Sistemas de Medicação no Hospital/normas , Recursos Humanos em Hospital/educação , Guias de Prática Clínica como Assunto , Vancomicina/uso terapêuticoAssuntos
Antibacterianos/efeitos adversos , Terapia por Infusões no Domicílio/efeitos adversos , Transplante de Rim/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/administração & dosagem , Bacteriemia/tratamento farmacológico , Celulite (Flegmão)/tratamento farmacológico , Humanos , Infusões Parenterais , Pessoa de Meia-Idade , Osteomielite/tratamento farmacológico , Infecções Urinárias/tratamento farmacológicoRESUMO
Fungal infections are a leading cause of morbidity and mortality among immunocompromised patients. Invasive fungal sinusitis is a devastating complication of immunosuppression. Treatment options are limited and often ineffective, making prevention important. Measures to decrease environmental exposure, indications for antifungal prophylaxis, and limitations of current regimens are discussed.
Assuntos
Antifúngicos/uso terapêutico , Hospedeiro Imunocomprometido , Micoses , Doenças dos Seios Paranasais , Humanos , Doenças dos Seios Paranasais/diagnóstico , Doenças dos Seios Paranasais/imunologia , Doenças dos Seios Paranasais/microbiologia , Doenças dos Seios Paranasais/prevenção & controle , Fatores de Risco , Tomografia Computadorizada por Raios XRESUMO
SETTING: A community health worker (CHW) program was established in Neno District, Malawi, in 2007 by Partners In Health in support of Ministry of Health activities. Routinely generated CHW data provide critical information for program monitoring and evaluation. Informal assessments of the CHW reports indicated poor quality, limiting the usefulness of the data. OBJECTIVES: 1) To establish the quality of aggregated measures contained in CHW reports; 2) to develop interventions to address poor data quality; and 3) to evaluate changes in data quality following the intervention. DESIGN: We developed a lot quality assurance sampling-based data quality assessment tool to identify sites with high or low reporting quality. Following the first assessment, we identified challenges and best practices and followed the interventions with two subsequent assessments. RESULTS: At baseline, four of five areas were classified as low data quality. After 8 months, all five areas had achieved high data quality, and the reports generated from our electronic database became consistent and plausible. CONCLUSION: Program changes included improving the usability of the reporting forms, shifting aggregation responsibility to designated assistants and providing aggregation support tools. Local quality assessments and targeted interventions resulted in immediate improvements in data quality.
RESUMO
Three hundred sixty-one quinupristin-dalfopristin (Q-D)-resistant Enterococcus faecium (QDREF) isolates were isolated from humans, turkeys, chickens, swine, dairy and beef cattle from farms, chicken carcasses, and ground pork from grocery stores in the United States from 1995 to 2003. These isolates were evaluated by pulsed-field gel electrophoresis (PFGE) to determine possible commonality between QDREF isolates from human and animal sources. PCR was performed to detect the streptogramin resistance genes vatD, vatE, and vgbA and the macrolide resistance gene ermB to determine the genetic mechanism of resistance in these isolates. QDREF from humans did not have PFGE patterns similar to those from animal sources. vatE was found in 35%, 26%, and 2% of QDREF isolates from turkeys, chickens, and humans, respectively, and was not found in QDREF isolates from other sources. ermB was commonly found in QDREF isolates from all sources. Known streptogramin resistance genes were absent in the majority of isolates, suggesting the presence of other, as-yet-undetermined, mechanisms of Q-D resistance.
Assuntos
Animais Domésticos/microbiologia , Antibacterianos/farmacologia , Farmacorresistência Bacteriana/genética , Enterococcus faecium/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/microbiologia , Carne/microbiologia , Virginiamicina/farmacologia , Animais , Proteínas de Bactérias/genética , Bovinos/microbiologia , Galinhas/microbiologia , Eletroforese em Gel de Campo Pulsado , Enterococcus faecium/genética , Enterococcus faecium/isolamento & purificação , Humanos , Perus/microbiologia , Estados UnidosRESUMO
Trends in the species of yeast causing fungaemia over a 12-year period at a large tertiary care medical centre were reviewed. A total of 966 unique episodes of fungaemia occurred in 898 patients. There was an overall trend toward fewer fungaemic episodes due to Candida albicans and more due to Candida glabrata and Candida parapsilosis. However, C. albicans remained the predominant species causing fungaemia, and the proportion due to other species varied from year to year. Candida glabrata was disproportionately isolated from older adults, whereas C. parapsilosis was common among neonates and infants. The trends of increasing isolation of C. glabrata and decreasing isolation of C. albicans were associated with increasing usage of fluconazole, but changes in the proportion of fungaemias due to other species appeared to have no association with fluconazole usage.
Assuntos
Candida/classificação , Candidíase/microbiologia , Fungemia/microbiologia , Centros Médicos Acadêmicos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Candida/isolamento & purificação , Criança , Pré-Escolar , Registros Hospitalares , Humanos , Lactente , Recém-Nascido , Michigan , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de TempoRESUMO
From 19 February 1999 through 31 October 1999, 16 (8.6%) of 185 patients who underwent median sternotomy developed infections with Pseudomonas aeruginosa. Seven patients had mediastinitis, 5 had deep sternal wound infection, 2 had superficial sternal wound infection, 1 had prosthetic valve endocarditis, and 1 had sepsis. Pulsed-field gel electrophoresis confirmed that all 13 isolates that were available for typing were the same strain. Cultures of hand specimens identified 1 nurse from whom the same strain of P. aeruginosa was repeatedly isolated; the nurse had been in contact with all 16 infected patients. Investigation revealed that the nurse had severe onycholysis and onychomycosis of the right thumbnail. Cultures of samples of this nail's subungual region and of multiple cosmetic products from the nurse's home yielded the identical P. aeruginosa strain. This outbreak of surgical site infections due to P. aeruginosa was caused by wound contamination from the thumbnail of this nurse, despite her appropriate use of latex surgical gloves.
Assuntos
Infecção Hospitalar/etiologia , Transmissão de Doença Infecciosa do Profissional para o Paciente , Enfermeiras e Enfermeiros , Infecções por Pseudomonas/transmissão , Esterno/cirurgia , Infecção da Ferida Cirúrgica/etiologia , Estudos de Casos e Controles , Infecção Hospitalar/transmissão , Eletroforese em Gel de Campo Pulsado , Humanos , Controle de Infecções , Doenças da Unha/microbiologia , Onicomicose/microbiologia , Infecções por Pseudomonas/etiologia , Pseudomonas aeruginosa/genéticaRESUMO
We report the case of a 32-year-old renal transplant recipient who developed disseminated Dactylaria constricta infection. The patient died despite treatment with amphotericin B, itraconazole, and fluconazole.